Linear accelerator–based stereotactic arrhythmia radioablation for paroxysmal atrial fibrillation in elderly patients: results from long-term follow-up - Takeaways - MDSpire

Long-term Outcomes of Stereotactic Arrhythmia Radioablation Using Linear Accelerators for Paroxysmal Atrial Fibrillation in Older Adults

  • By

  • Antonio Di Monaco

  • Imma Romanazzi

  • Ilaria Bonaparte

  • Alessia Surgo

  • Alba Fiorentino

  • Massimo Grimaldi

  • July 20, 2026

Share

  • 1

    Stereotactic arrhythmia radioablation (STAR) is evaluated for its safety and feasibility in elderly patients with paroxysmal atrial fibrillation.

  • 2

    Eighteen out of twenty enrolled patients underwent STAR, with long-term follow-up maintained through clinical evaluations and structured interviews.

  • 3

    At 12 months post-STAR, 44% of patients developed mild pericardial effusion, which resolved in most by the long-term follow-up.

  • 4

    Quality of life significantly improved from 48 ± 15 at enrollment to 75 ± 15 at 12 months after STAR treatment.

  • 5

    No serious adverse events occurred during the follow-up, with mild esophagitis being the most common side effect, which resolved fully.

Original Source(s)

Linear accelerator–based stereotactic arrhythmia radioablation for paroxysmal atrial fibrillation in elderly patients: results from long-term follow-up

  • by Antonio Di Monaco, Imma Romanazzi, Ilaria Bonaparte, Alessia Surgo, Alba Fiorentino, Massimo Grimaldi

  • July 20, 2026

Related Content

Effectiveness and safety of Guipi Mixture for the treatment of premature ventricular contractions (heart-spleen deficiency syndrome): study protocol for a randomized, double-blind, placebo-controlled, multicentre trial

Segmental analysis of left atrial substrate severity predictors in patients undergoing persistent atrial fibrillation ablation

Ambulatory Fetal Heart Rate and Rhythm Monitoring for Pregnancies at Risk for Fetal Arrhythmias: Perspectives from the Fetal Heart Society